Download video

Exploring ABBV-400 in second-line colorectal cancer treatment

139 views

VJOncology

9 months ago

Exploring ABBV-400 in second-line colorectal cancer treatment

Exploring ABBV-400 in second-line colorectal cancer treatment

Exploring ABBV-400 in second-line colorectal cancer treatment
1:10
Exploring ABBV-400 in second-line colorectal cancer treatment
by VJOncology
EMBARK: metastasis-free survival by prior treatment in hrBCR prostate cancer
0:55
EMBARK: metastasis-free survival by prior treatment in hrBCR prostate cancer
by VJOncology
Breakthrough in Cancer Treatment: 212Pb-DOTAMTATE for Advanced Neuroendocrine Tumors
8:44
Breakthrough in Cancer Treatment: 212Pb-DOTAMTATE for Advanced Neuroendocrine Tumors
by New Wave Media
Perioperative Pembrolizumab Doubles Survival in Metastatic Bladder Cancer
1:12
Perioperative Pembrolizumab Doubles Survival in Metastatic Bladder Cancer
by Targeted Oncology
HER-2 Positive Cancer Treatments (2025)
59:18
HER-2 Positive Cancer Treatments (2025)
by OCRA
Targeting Cancer at the Molecular Level: Repurposed Drugs and Integrative Strategies
58:39
Targeting Cancer at the Molecular Level: Repurposed Drugs and Integrative Strategies
by Fit Rx Health + Wellness
Intratumoral Vitamin C - Part 2
17:44
Intratumoral Vitamin C - Part 2
by Williams Cancer Institute
INLURIYO (imlunestrant) - Breast Cancer! #saroarakelians #pharmacytalkusa #breastcancer #cancer
3:04
INLURIYO (imlunestrant) - Breast Cancer! #saroarakelians #pharmacytalkusa #breastcancer #cancer
by Pharmacy Talk USA
Early results from EVEREST-2 of A2B694, a CAR T therapy, in solid tumors
0:39
Early results from EVEREST-2 of A2B694, a CAR T therapy, in solid tumors
by VJOncology
INTEGRATE IIb: regorafenib plus nivolumab in advanced gastric cancer
1:27
INTEGRATE IIb: regorafenib plus nivolumab in advanced gastric cancer
by VJOncology
Results From Amivanatamab Clinical Trial for Metastatic Colorectal Cancer
5:39
Results From Amivanatamab Clinical Trial for Metastatic Colorectal Cancer
by CheckRare
CARES-009: perioperative camrelizumab and rivoceranib in resectable HCC
3:15
CARES-009: perioperative camrelizumab and rivoceranib in resectable HCC
by VJOncology